Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Mimi Israël is active in eating disorders, affective disorders, crisis intervention, emergency psychiatry and mental health care service organization.

Hani Iskandar has been involved in clinical research projects in the fields of schizophrenia, mood disorders and pharmacology.  

David Bloom treats and ensures follow-up for patients who suffer from schizophrenia and bipolar disorder.

Serge Gauthier has contributed to the development of new diagnostic and therapeutic approaches to Alzheimer's Disease and other dementing disorders.  

Jean-Bruno Debruille studies the processes that precede and permit the conscious perception using fMRI and ERPs.

Anne Crocker, PhD, focuses her work on the interface between mental health and the law.

Nicolas Cermakian is studying the molecular mechanisms underlying circadian rhythms, especially in animal models.